EN
FR
Export
export
Export
PDF
Excel (XLSX)
Word (DOCX)
You can select particular sections to be included in the output file.
Select all
Select classic EML layout
Indication
ICD-11
ATC codes
List type
Formulations
Therapeutic alternatives
Footnote
INN
Medicine type
Antibiotic groups
Sex
Age
Age restriction
Weight restriction
Patent information
Expert Committee decision justification
Cancel
Download
EN
FR
Model List of Essential Medicines
clear
Found 22 recommendations for 15 medicines and 3 therapeutic equivalents
Removed recommendations and rejected applications are shown.
Hide them
.
11. Blood products of human origin and plasma substitutes
Anti-D immunoglobulin
General information
Section
Human immunoglobulins
Parenteral > General injections > IV: 250 µg in single-dose vial
Parenteral > General injections > IM: 250 µg in single-dose vial
Indications
Maternal care for red cell antibodies
Rh incompatibility reaction
Anti-rabies immunoglobulin
General information
Section
Human immunoglobulins
Parenteral > General injections > IM: 150 IU per mL in vial
Parenteral > Locoregional injections > Other: 150 IU per mL in vial
Indications
Rabies
Anti-tetanus immunoglobulin
General information
Section
Human immunoglobulins
Parenteral > General injections > IM: 500 IU in vial
Indications
Tetanus
C1 esterase inhibitor
General information
Section
Plasma-derived medicines
Parenteral > General injections > IV: 500 IU in vial powder for injection
Indications
Hereditary angioedema
Coagulation factor IX
General information
Section
Blood coagulation factors
Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection
Indications
Coagulation defects, purpura or other haemorrhagic or related conditions
Haemophilia B
Coagulation factor IX complex
General information
Section
Blood coagulation factors
Indications
Therapeutic equivalent to
coagulation factor IX
for
Coagulation defects, purpura or other haemorrhagic or related conditions
Therapeutic equivalent to
coagulation factor IX
for
Haemophilia B
Coagulation factor VIII
General information
Section
Blood coagulation factors
Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection
Indications
Haemophilia A
Cryoprecipitate (not pathogen-reduced)
General information
Section
Blood and blood components
Indications
Therapeutic equivalent to
cryoprecipitate (pathogen-reduced)
for
Haemophilia A
Therapeutic equivalent to
cryoprecipitate (pathogen-reduced)
for
Coagulation defects, purpura or other haemorrhagic or related conditions
Therapeutic equivalent to
cryoprecipitate (pathogen-reduced)
for
Von Willebrand disease
Therapeutic equivalent to
cryoprecipitate (pathogen-reduced)
for
Obstetric haemorrhage
Cryoprecipitate (pathogen-reduced)
General information
Section
Blood and blood components
Injection: frozen liquid in bag or lyophilized powder in vial containing:
> 50 IU Factor VIII
> 100 IU vWF
> 140 mg clottable fibrinogen per unit
Indications
Haemophilia A
Coagulation defects, purpura or other haemorrhagic or related conditions
Von Willebrand disease
Obstetric haemorrhage
Dextran 40
General information
Section
Plasma substitutes
.
Indications
Hypovolaemia
Dextran 70
General information
Section
Plasma substitutes
Parenteral > General injections > IV: 6% injectable solution
Indications
Hypovolaemia
Fresh-frozen plasma
General information
Section
Blood and blood components
Parenteral > General injections > IV:
Indications
Blood transfusion without reported diagnosis
Normal immunoglobulin
General information
Section
Human immunoglobulins
Parenteral > General injections > IV: 5% protein solution; 10% protein solution
Parenteral > General injections > IM: 16% protein solution
Parenteral > General injections > SC: 15% protein solution; 16% protein solution
Indications
Primary immunodeficiencies
Mucocutaneous lymph node syndrome
Langerhans cell histiocytosis
Platelets
General information
Section
Blood and blood components
Parenteral > General injections > IV:
Indications
Blood transfusion without reported diagnosis
Polygeline
General information
Section
Plasma substitutes
Parenteral > General injections > IV: 3.5% injectable solution
Parenteral > General injections > IV: 3.5% in solution
Indications
Therapeutic equivalent to
dextran 70
for
Hypovolaemia
Hypovolaemia
Red blood cells
General information
Section
Blood and blood components
Parenteral > General injections > IV:
Indications
Blood transfusion without reported diagnosis
Whole blood
General information
Section
Blood and blood components
Parenteral > General injections > IV:
Indications
Blood transfusion without reported diagnosis